> top > projects > yaoziqian_800_3 > docs > PubMed:29955381 > annotations

PubMed:29955381 JSONTXT 6 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T21 17-27 CI denotes adalimumab
T2 89-99 CI denotes adalimumab
T3 105-117 CI denotes methotrexate
T1 135-155 DP denotes rheumatoid arthritis
T4 293-313 DP denotes rheumatoid arthritis
T34 315-317 DP denotes RA
T5 329-339 CI denotes adalimumab
T6 355-365 CI denotes adalimumab
T7 366-378 CI denotes methotrexate
T8 435-445 CI denotes adalimumab
T9 446-458 CI denotes methotrexate
T10 469-481 CI denotes Methotrexate
T11 508-510 DP denotes RA
T12 530-540 CI denotes adalimumab
T13 542-554 CI denotes methotrexate
T14 558-568 CI denotes adalimumab
T15 570-582 CI denotes methotrexate
T16 755-765 CI denotes adalimumab
T36 830-842 CI denotes methotrexate
T17 982-992 CI denotes adalimumab
T35 993-1009 CI denotes methotrexate who
T19 1045-1055 CI denotes adalimumab
T20 1071-1083 CI denotes methotrexate
T23 1314-1324 CI denotes adalimumab
T24 1356-1366 CI denotes adalimumab
T27 1373-1385 CI denotes methotrexate
T25 1420-1432 CI denotes methotrexate
T26 1434-1446 CI denotes methotrexate
T28 1501-1513 CI denotes methotrexate
T29 1550-1562 CI denotes methotrexate
T30 1822-1834 CI denotes methotrexate
T31 1874-1884 CI denotes Adalimumab
T32 2055-2065 CI denotes adalimumab
T33 2066-2086 CI denotes methotrexate therapy